Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (111-120 of 492) with videos related to

Pageof 50
Sort By:
Antibiotics (Basel, Switzerland)|April 23, 2022
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing <i>Enterobacterales</i> in Patients with Invasive Urinary Tract Infection Considering Renal FunctionYukihiro Hamada, Hidefumi Kasai, Moeko Suzuki-Ito, et al.
Diabetes, Obesity & Metabolism|June 29, 2023
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trialYohei Doi, Takayuki Hamano, Satoshi Yamaguchi, et al.
Emerging Infectious Diseases|March 17, 2016
New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae, Florida, USA(1)Jun-Jie Li, L Silvia Munoz-Price, Caressa N Spychala, et al.
Kidney International|December 21, 2024
A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in JapanMaki Shinzawa, Isao Matsui, Yohei Doi, et al.
Journal of Global Antimicrobial Resistance|February 19, 2025
In vitro activity of aztreonam in combination with relebactam against gram-negative pathogens producing various serine and metallo-β-lactamasesKengo Hayashi, Masahiro Suzuki, Yoshikazu Ishii, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 21, 2019
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumanniiSarunyou Chusri, Kamonnut Singkhamanan, Worrawit Wanitsuwan, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosaGuo-Bao Tian, Jennifer M Adams-Haduch, Tatiana Bogdanovich, et al.
Microbial Genomics|September 19, 2024
Evaluation of <i>Klebsiella pneumoniae</i> pathogenicity through holistic gene content analysisMiyu Isogai, Kumiko Kawamura, Tetsuya Yagi, et al.
Journal of Clinical Microbiology|January 1, 2016
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor CombinationsGina K Thomson, James W Snyder, Christi L McElheny, et al.
Research in Microbiology|September 19, 2017
Susceptibility of colistin-resistant pathogens to predatory bacteriaSonal Dharani, Dong Hyun Kim, Robert M Q Shanks, et al.
Pageof 50

Showing results (111-120 of 492) with videos related to

Sort By:
Pageof 50
Antibiotics (Basel, Switzerland)|April 23, 2022
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing <i>Enterobacterales</i> in Patients with Invasive Urinary Tract Infection Considering Renal FunctionYukihiro Hamada, Hidefumi Kasai, Moeko Suzuki-Ito, et al.
Diabetes, Obesity & Metabolism|June 29, 2023
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trialYohei Doi, Takayuki Hamano, Satoshi Yamaguchi, et al.
Emerging Infectious Diseases|March 17, 2016
New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae, Florida, USA(1)Jun-Jie Li, L Silvia Munoz-Price, Caressa N Spychala, et al.
Kidney International|December 21, 2024
A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in JapanMaki Shinzawa, Isao Matsui, Yohei Doi, et al.
Journal of Global Antimicrobial Resistance|February 19, 2025
In vitro activity of aztreonam in combination with relebactam against gram-negative pathogens producing various serine and metallo-β-lactamasesKengo Hayashi, Masahiro Suzuki, Yoshikazu Ishii, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 21, 2019
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumanniiSarunyou Chusri, Kamonnut Singkhamanan, Worrawit Wanitsuwan, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosaGuo-Bao Tian, Jennifer M Adams-Haduch, Tatiana Bogdanovich, et al.
Microbial Genomics|September 19, 2024
Evaluation of <i>Klebsiella pneumoniae</i> pathogenicity through holistic gene content analysisMiyu Isogai, Kumiko Kawamura, Tetsuya Yagi, et al.
Journal of Clinical Microbiology|January 1, 2016
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor CombinationsGina K Thomson, James W Snyder, Christi L McElheny, et al.
Research in Microbiology|September 19, 2017
Susceptibility of colistin-resistant pathogens to predatory bacteriaSonal Dharani, Dong Hyun Kim, Robert M Q Shanks, et al.
Pageof 50